Day: May 25, 2020

G A U M O N TSociété anonyme au capital de 24 959 384 eurosSiège social 30, avenue Charles de Gaulle 92200 Neuilly sur Seine562 018 002 R.C.S. NanterreAssemblée Générale Mixte des actionnaires de GaumontMardi 16 juin 2020 à 11 heuresà huis clos au siège socialL’avis de réunion comportant l’ordre du jour et les projets de résolution relatifs à cette Assemblée Générale a été publié au Bulletin des Annonces Légales Obligatoires n° 54 du 4 mai 2020. Il est accessible sur les sites internet www.gaumont.fr et www.journal-officiel.gouv.frL’avis de convocation relatif à cette Assemblée Générale est publié au Bulletin des Annonces Légales Obligatoires n° 63 et dans le journal Petites Affiches (Hauts-de-Seine) du 25 mai 2020. Il est disponible sur les sites internet www.gaumont.fr et www.journal-officiel.gouv.frTous les documents...

VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) — Gold X Mining Corp. (TSX-V: GLDX, OTCQX: SSPXF) (“Gold X” or the “Company”) announces that, further to its news release dated May 11, 2020, Gran Colombia Gold Corp. (“Gran Colombia”) has decided to no longer pursue the acquisition of all of the issued and outstanding common shares of Guyana Goldfields Inc.  As a result, Gran Colombia and Gold X have agreed to terminate the Plan of Arrangement between Gran Colombia and Gold X dated May 11, 2020.Paul Matysek, Chairman and CEO stated “While we believe that the Gran Colombia Gold proposal to combine one of the largest gold resources in the Americas with Aurora’s operating mine and process facility created many synergies that would result in significant value creation for the shareholders of all three companies, we respect...

Company announcement, Helsinki, 25.5.2020 AT 8 PM (EET)Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD),  announces manager’s transactions as follows:Person subject to the notification requirementName: Kaikarhenni OyPosition: Closely associated person(X) Legal person(1):Person Discharging Managerial Responsibilities In IssuerName: Leena NiemistöPosition: Member of the BoardIssuer: Nexstim OyjLEI: 743700S7ZI0LNMHZ6Y27Notification type: INITIAL NOTIFICATIONReference number: 743700S7ZI0LNMHZ6Y27_20200525112333_10____________________________________________Transaction date: 2020-05-22Venue: FIRST NORTH FINLAND (FNFI)Instrument type: SHAREISIN: FI4000354162Nature of the...

Yhtiötiedote, Helsinki, 25.5.2020,  20.00Nexstim Oyj (NXTMH:HEX, NXTMS:STO) (”Nexstim” tai ”Yhtiö”), neuromodulaatioyritys, joka markkinoi kehittämäänsä uraauurtavaa aivostimulaatioteknologiaa vakavan masennuksen yksilölliseen hoitoon, ilmoittaa johdon liiketoimista seuraavasti:IlmoitusvelvollinenNimi: Kaikarhenni OyAsema: Lähipiiriin kuuluva henkilö(X) Oikeushenkilö(1):Liikkeeseenlaskijassa johtotehtävissä toimiva henkilöNimi: Leena NiemistöAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: Nexstim OyjLEI: 743700S7ZI0LNMHZ6Y27Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700S7ZI0LNMHZ6Y27_20200525104819_9____________________________________________Liiketoimen päivämäärä: 2020-05-22Kauppapaikka: FIRST NORTH FINLAND (FNFI)Instrumenttityyppi: OSAKEISIN: FI4000354162Liiketoimen luonne: MERKINTÄ(X) Liiketoimi on tehty omaisuudenhoidon...

Företagsmeddelande, Helsingfors, 25.5.2020, 20.00Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”), ett företag inom neuromodulering som tagit fram och marknadsför en banbrytande teknik för hjärnstimulering för individanpassad behandling av egentlig depression, meddelar av följande transaktioner utförda av personer i ledande ställning:Den anmälningsskyldigaNamn: Kaikarhenni OyBefattning: Närstående person(X) Juridisk person(1):Person i ledande ställning hos emittentenNamn: Leena NiemistöBefattning: Styrelseledamot/suppleantEmittent: Nexstim OyjLEI: 743700S7ZI0LNMHZ6Y27Anmälans karaktär: FÖRSTA ANMÄLANReferensnummer: 743700S7ZI0LNMHZ6Y27_20200525112333_10____________________________________________Transaktionens datum: 2020-05-22Handelsplats: FIRST NORTH FINLAND (FNFI)Typ av instrument: AKTIEISIN: FI4000354162Transaktionens...

 Schlieren/Switzerland, 25 May 2020AttachmentEGM_Adhoc

Úlfar Freyr Stefánsson has been appointed Chief Risk Officer of Arion Bank. Úlfar is taking over from Gísli S. Óttarsson who will be leaving the Bank after having been Chief Risk Officer and a member of the Bank’s executive committee since 2009. Gísli will step down at the end of the month but will continue to work in an advisory capacity for the Bank.Úlfar joined the Bank’s Risk Management division in 2013 after having worked at Kaupthing since 2010, where his positions included head of risk management. Úlfar was Head of Portfolio Risk at Arion Bank from 2013 to 2015, when he took over as Head of Balance Sheet Risk. Úlfar has a doctorate in mathematics from Georgia Institute of Technology and a master’s from the same institution. He also has a BSc in mathematics from the University of Iceland and is a certified securities broker.Benedikt...

Úlfar Freyr Stefánsson hefur verið ráðinn framkvæmdastjóri áhættustýringar Arion banka. Úlfar tekur við af Gísla S. Óttarssyni sem komist hefur að samkomulagi við bankann um starfslok eftir að hafa sinnt starfi framkvæmdastjóra áhættustýringar og setið í framkvæmdastjórn bankans frá árinu 2009. Gísli mun láta af störfum um næstu mánaðamót en sinna áfram ráðgjafarverkefnum fyrir bankann.Úlfar hóf störf í áhættustýringu Arion banka árið 2013 eftir að hafa starfað hjá Kaupþingi frá árinu 2010, m.a. sem framkvæmdastjóri áhættustýringar. Úlfar var forstöðumaður eignasafnsáhættu Arion banka á árunum 2013-2015 er hann tók við sem forstöðumaður efnahagsáhættu innan áhættustýringar. Úlfar er doktor í stærðfræði frá Georgia Institute of Technology og með meistarapróf frá sama skóla. Hann er jafnframt með B.S. gráðu í stærðfræði frá Háskóla Íslands...

Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaborationPARIS – May 25, 2020 – Sanofi today announced its intent to sell its equity investment in Regeneron (NASDAQ: REGN) through a registered public offering and related share repurchase by Regeneron. The registered offering and share repurchase will have no impact on the ongoing collaboration between Sanofi and Regeneron.A preliminary prospectus supplement relating to the offering of Regeneron’s shares will be filed with the U.S. Securities and Exchange Commission. Sanofi currently holds approximately 23.2 million shares of Regeneron’s common stock, representing approximately 20.6% ownership.Regeneron has agreed to repurchase $5 billion of its stock from Sanofi conditional on completion of the proposed public offering. If the offering...

Sanofi a l’intention de céder sa participation au capital de Regeneron ; leur collaboration en cours reste inchangéePARIS – Le 25 mai 2020 – Sanofi annonce aujourd’hui son intention de céder sa participation au capital de Regeneron (NASDAQ: REGN) par voie d’offre publique et de rachat d’actions par Regeneron. L’offre publique et le rachat d’actions n’auront aucun impact sur la collaboration en cours entre Sanofi et Regeneron.Un supplément de prospectus provisoire relatif à l’offre sera déposé auprès de la Securities and Exchange Commission des États-Unis. Sanofi détient actuellement 23,2 millions d’actions ordinaires de Regeneron, soit une participation d’environ 20,6 %.Regeneron a accepté de racheter pour 5 milliards de dollars de ses actions à Sanofi, sous réserve de la finalisation de l’offre publique. A l’issue de l’offre et...